Zurich Cantonal Bank’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,983
Closed -$179K 2962
2022
Q3
$179K Buy
+8,983
New +$118K ﹤0.01% 1822

Zurich Cantonal Bank's FMTX Position: Q4 2022 in Review

Zurich Cantonal Bank sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 8,983 shares — an estimated $179K sold.

Zurich Cantonal Bank first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $179K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Zurich Cantonal Bank reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 8,983 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $179K.
  • Zurich Cantonal Bank first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Zurich Cantonal Bank's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $179K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Zurich Cantonal Bank's 13F filing for Q4 2022, filed 1 Feb 2023.